|
Oct 23
|
Immutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer
|
|
Oct 18
|
It May Be Possible That Immutep Limited's (ASX:IMM) CEO Compensation Could Get Bumped Up
|
|
Sep 5
|
Immutep to Participate in September Investor Conferences
|
|
Aug 3
|
Qualcomm downgraded, Wingstop upgraded: Wall Street's top analyst calls
|